Abstract:Abstract Background The small number of samples and the curse of dimensionality hamper the better application of deep learning techniques for disease classification. Additionally, the performance of clustering-based feature selection algorithms is still far from being satisfactory due to their limitation in using unsupervised learning methods. To enhance interpretability and overcome this problem, we developed a novel feature selection algorithm. In the meantime, complex genomic data brought great challenges for the identification of biomarkers and therapeutic targets. The current some feature selection methods have the problem of low sensitivity and specificity in this field. Results In this article, we designed a multi-scale clustering-based feature selection algorithm named MCBFS which simultaneously performs feature selection and model learning for genomic data analysis. The experimental results demonstrated that MCBFS is robust and effective by comparing it with seven benchmark and six state-of-the-art supervised methods on eight data sets. The visualization results and the statistical test showed that MCBFS can capture the informative genes and improve the interpretability and visualization of tumor gene expression and single-cell sequencing data. Additionally, we developed a general framework named McbfsNW using gene expression data and protein interaction data to identify robust biomarkers and therapeutic targets for diagnosis and therapy of diseases. The framework incorporates the MCBFS algorithm, network recognition ensemble algorithm and feature selection wrapper. McbfsNW has been applied to the lung adenocarcinoma (LUAD) data sets. The preliminary results demonstrated that higher prediction results can be attained by identified biomarkers on the independent LUAD data set, and we also structured a drug-target network which may be good for LUAD therapy. Conclusions The proposed novel feature selection method is robust and effective for gene selection, classification, and visualization. The framework McbfsNW is practical and helpful for the identification of biomarkers and targets on genomic data. It is believed that the same methods and principles are extensible and applicable to other different kinds of data sets.

Tumor Classification Via Sparse Representation Based on Metasample

An integrated inverse space sparse representation framework for tumor classification

Low Rank Variation Dictionary and Inverse Projection Group Sparse Representation Model for Breast Tumor Classification

SGL-SVM: A novel method for tumor classification via support vector machine with sparse group Lasso

Inverse Projection Representation and Category Contribution Rate for Robust Tumor Recognition

Collaborative Representation-Based Classification of Microarray Gene Expression Data

Tumor Classification Using Non-negative Matrix Factorization

Tumor gene expression data classification via sample expansion-based deep learning

Multiclass Cancer Classification by Using Fuzzy Support Vector Machine and Binary Decision Tree with Gene Selection

Diagnosis of Benign and Malignant Renal Tumors Based on Multi-Feature Sparse Constraints.

Bi-level gene selection of cancer by combining clustering and sparse learning

Dynamic Meta-data Network Sparse PCA for Cancer Subtype Biomarker Screening

T Cell Receptor Protein Sequences and Sparse Coding: A Novel Approach to Cancer Classification

A Self-Training Subspace Clustering Algorithm under Low-Rank Representation for Cancer Classification on Gene Expression Data

[The host-loyalty index of fleas, its analysis and importance in plague epizootiology].

Detection and Localization of Solid Tumors Utilizing the Cancer-Type-Specific Mutational Signatures

Overall Survival Time Prediction for High Grade Gliomas Based on Sparse Representation Framework.

Multi-scale supervised clustering-based feature selection for tumor classification and identification of biomarkers and targets on genomic data

Supervised Discriminative Sparse PCA for Com-Characteristic Gene Selection and Tumor Classification on Multiview Biological Data

Discriminative Localized Sparse Representations for Breast Cancer Screening

Deep Representation Learning of Tissue Metabolome and Computed Tomography Images Annotates Non-invasive Classification and Prognosis Prediction of NSCLC